Introduction {#s1}
============

Following the recent advances in machine learning, deep generative models found many applications in biomedicine, including drug discovery, biomarker development, and drug repurposing ([@B36]; [@B66]). A promising approach to drug discovery is conditional generation, where a machine learning model learns a distribution *p*(*x* \| *y*) of molecular structures *x* with given property *y*. Such models can generate molecules with a given synthetic accessibility, binding energy, or even activity against a given protein target ([@B23]; [@B45]).

In this paper, we studied how conditional models scale to a more complex biological property; specifically, we have studied how drug incubation influences gene expression profiles. Using the LINCS L1000 ([@B15]) dataset, we build a joint model *p*(*x*, *y*) on molecular structures *x* and induced gene expression changes *y*.

In many conditional generation tasks, *x* completely defines *y*. For example, molecular structure completely defines its synthetic accessibility score. For our task, however, some transcriptome changes are unrelated to the drug effect on cells, and we cannot infer them only from an incubated drug.

We propose a new model---the Bidirectional Adversarial Autoencoder---that learns a joint distribution *p*(*x*, *y*) of objects and conditions. The model decomposes objects and their properties into three feature parts: shared features *s* common to both *x* and *y*; exclusive features *z~x~* relevant only to *x* and not *y*; and exclusive features *z~y~* relevant only to *y* and not *x*: *p*(*x*, *y*) = *p*(*s*, *z~x~*, *z~y~*). For the transcriptomes and drugs, shared features *s* may contain pharmacophore properties, target protein information, binding energy, and inhibition level; exclusive features *z~x~* may describe the remaining structural information; and *z~y~* may represent unrelated cellular processes. As features *s* are common to both *x* and *y*, the model can extract them from both *x* and *y*.

The paper is organized into sections: *Related Work* surveys related work; *Models* presents the proposed Bidirectional Adversarial Autoencoder; *Experimental Evaluation* compares and validates the models on two datasets: the toy Noisy MNIST dataset of hand-written digits and LINCS L1000 dataset of small molecules with corresponding gene expression changes; and *Conclusion* concludes the paper.

Related Work {#s2}
============

Conditional generative models generate objects *x* from a conditional distribution *p*(*x* \| *y*), with *y* usually being limited to class labels. The Adversarial Autoencoder (AAE) ([@B35]) consists of an autoencoder with a discriminator on the latent representation *z* that tries to make the latent space distribution indistinguishable from a prior distribution *p*(*z*); its conditional extension---Supervised AAE ([@B35])---works well for simple conditions but can violate the conditions in other cases ([@B46]). Conditional Generative Adversarial Networks (CGAN) ([@B41]) supplied the condition as an auxiliary input to both generator and discriminator. [@B44] inverted CGANs, allowing us to edit images by changing the labels *y*. In FusedGAN ([@B8]), a GAN generated a generic "structure prior" with no supervision, and a CGAN generated an object *x* from condition *y* and the latent representation learned by the unconditional GAN. Other papers explored applications of Conditional AAE models to the task of image modification ([@B5]; [@B30]; [@B63]).

CausalGAN ([@B28]) allowed components of the condition to have a dependency structure in the form of a causal model making conditions more complex. The Bayesian counterpart of AAE, the Variational Autoencoder (VAE) ([@B27]), also had a conditional version ([@B53]), where conditions improved structured output prediction. CycleGAN ([@B68]) examined a related task of object-to-object translation.

Multimodal learning models ([@B42]) and multi-view representation models ([@B57]) explored translations between different modalities, such as image to text. [@B58] presented a VAE-based generative multi-view model. Our Bidirectional Adversarial Autoencoder provided explicit decoupling of latent representations and brought the multi-view approach into the AAE framework, where the basic Supervised AAE-like models ([@B35]) did not yield correct representations for sampling ([@B46]).

Information decoupling ideas have been previously applied in other contexts: [@B62] disentangled identity and pose factors of a 3D object; adversarial architecture from [@B40] decoupled different factors in latent representations to transfer attributes between objects; [@B14] used VAE architecture with separate encoders for class label *y* and latent representation *z*, forcing *z* to exclude information about *y*; InfoVAE ([@B64]) maximized mutual information between input and latent features; and [@B31] proposed a VAE modification that explicitly learns a "disentangled" representation *s* to predict the class label and a "non-interpretable" representation *z* that contains the rest of the information used for decoding.

InfoGAN ([@B11]) maximized mutual information between a subset of latent factors and the generator distribution. FusedGAN ([@B8]) generated objects from two components, where only one component contains all object-relevant information. [@B22] explicitly disentangles different factors in the latent representation and maps a part of the latent code to a particular external information.

Conditional Generation for Biomedicine {#s2_1}
--------------------------------------

Machine learning has numerous applications in biomedicine and drug discovery ([@B18]; [@B36]; [@B13]). Deep neural networks demonstrated positive results in various tasks, such as prediction of biological age ([@B47]; [@B37]; [@B39]), prediction of targets and side effects [@B4]; [@B38]; [@B61]), and applications in medicinal chemistry ([@B33]; [@B34]).

Alongside large-scale studies that measure cellular processes, deep learning applications explore transcriptomics ([@B3]; [@B12]); these works study cellular processes and their change following molecular perturbations. Deep learning has also been applied to pathway analysis ([@B43]), the prediction of protein functions ([@B32]), the discovery of RNA binding proteins ([@B67]), the discovery of binding patterns of transcription factors ([@B50]), medical diagnostics based on omics data ([@B10]), and the analysis of DNA and RNA sequences ([@B9]).

In drug discovery, apart from predicting pharmacological properties and learning useful representations of small molecules ([@B16]; [@B2]; [@B29]), deep learning is being widely applied to the generation of molecules ([@B51]). Multiple authors have published models that generate new molecules that are similar to the training data or molecules with predefined properties ([@B24]; [@B25]; [@B52] [@B19]). AI-generated molecules have also been tested *in vitro* ([@B46]). Reinforcement learning and generative models further enabled the generation of complex non-differentiable objectives, such as novelty ([@B21]; [@B48]; [@B49]). Generative models aim to eliminate the bottleneck of traditional drug development pipelines by providing promising new lead molecules for a specific target and automating the initial proposal of lead molecules with desired properties. Recently, [@B65] developed a model GENTRL to discover potent inhibitors of discoidin domain receptor 1 (DDR1) in 21 days.

Models {#s3}
======

In this section, we introduce Unidirectional and a Bidirectional Adversarial Autoencoders and discuss their applications to conditional modeling. While we have focused on an example of molecular generation for transcriptome changes, in general, our model is not limited to these data types and can be used for generation in other domains.

Supervised Adversarial Autoencoder {#s3_1}
----------------------------------

Our model for conditional generation is based on a Supervised Adversarial Autoencoder (Supervised AAE, SAAE) ([@B35]) shown in [**Figure 1**](#f1){ref-type="fig"}. The Supervised AAE learns three neural networks---an encoder *E~x~*, a generator (decoder) *G~x~*, and a discriminator *D*. The encoder maps a molecule *x* onto a latent representation *z* = *E~x~*(*x*), and a generator reconstructs the molecule back from *z* and gene expression changes *y*: *G~x~*(*z, y*). We trained a discriminator *D* to distinguish latent codes from samples of the prior distribution *p*(*z*) and modified the encoder to make the discriminator believe that encoder's outputs are samples from the prior distribution:
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![The Supervised Adversarial Autoencoder model (SAAE).](fphar-11-00269-g001){#f1}

where $l_{\text{rec}}^{x}$ is a similarity measure between the original and reconstructed molecule, and *p*~d~(*x*, *y*) is the data distribution. Hyperparameter λ~1~ balances reconstruction and adversarial losses. We trained the model by alternately maximizing the loss in Equation 1 with respect to the parameters of *D* and minimizing it with respect to the parameters of *E~x~* and *G~x~* ([@B20]).

Besides passing gene expression changes *y* directly to the generator, we could also train an autoencoder (*E~y~*, *G~y~*) on *y* and pass its latent codes to the molecular decoder *G~x~* ([**Figure 2**](#f2){ref-type="fig"}). We call this model a Latent Supervised Adversarial Autoencoder (Latent SAAE). Its optimization problem is:
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![The Latent Supervised Adversarial Autoencoder model (Latent SAAE).](fphar-11-00269-g002){#f2}

Hyperparameters λ~1~ and λ~2~ balance object and condition reconstruction losses as well as the adversarial loss.

Bidirectional Adversarial Autoencoder {#s3_2}
-------------------------------------

Both SAAE and Latent SAAE models learn conditional distribution *p*(*x* \| *y*) of molecules for specific transcriptome changes. In this paper, we learned a joint distribution *p*(*x*, *y*) instead. Our model is symmetric in that it can generate both *x* for a given *y* and *y* for a given *x*. We assume that the data are generated with a graphical model shown in [**Figure 3**](#f3){ref-type="fig"}. Latent variables *z~x~* and *z~y~* are exclusive parts that represent features specific only to molecules or transcriptome changes. Latent variable *s* represents a shared part that describes features significant for both molecules and expression changes. To produce a new data point, we sampled exclusive (*z~x~*, *z~y~*) and shared (*s*) parts independently and used generative distributions *G~x~* (*x* \| *s*, *z~x~*) and *G~y~* (*y* \| *s*, *z~y~*) to produce *x* and *y*.

![The underlying graphical model of the data: molecules *x*, gene expression changes *y*, three latent variables correspond to the exclusive (*z*~*x*~, *z*~*y*~) and shared (*s*) features between *x* and *y*.](fphar-11-00269-g003){#f3}

To train a model, we used inference networks that predict values of *s*, *z~x~*, and *z~y~*: *E~x~*(*z~x~* **\|** *x*), *E~y~*(*z~y~* **\|** *y*), and *E*(*s* **\|** *x, y*) = *E~x~*(*s* **\|** *x*) = *E~y~*(*s* **\|** *y*). Note that we used two separate networks for inference of *s* from one of *x* and *y* to perform conditional sampling (when only one of *x* or *y* is known). For example, to sample *p*(*x* \| *y*), we would do the following steps:
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For the molecule, *s* may describe its pharmacophore---binding points that are recognized by macromolecules. For the gene expression, *s* may describe affected proteins. Note that we can infer pharmacophore from a list of affected genes and vice versa. The exclusive part *z~x~* of a molecule describes the remaining structural parts besides the pharmacophore points. The exclusive part *z~y~* of a transcriptome describes cellular processes that influence the expression but are not caused by the drug.

[**Figure 4**](#f4){ref-type="fig"} shows the proposed Bidirectional AAE architecture. We used two deterministic encoders *E~x~* and *E~y~* that infer latent codes from molecules and transcriptomes:
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![The Bidirectional Adversarial Autoencoders model. The discriminators ensure that three latent code components are independent and indistinguishable from the prior distribution.](fphar-11-00269-g004){#f4}

Two deterministic decoders (generators) *G~x~* and *G~y~* reconstruct molecules *x* and gene expression changes *y* back from the latent codes:
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The objective function consists of three parts, each capturing restrictions from the graphical model---the structure of the shared representation, reconstruction quality, and independence of shared and exclusive representations.

**Shared loss** ensures that shared representations extracted from the molecule *s~x~* and gene expression *s~y~* are close to each other, as suggested by the graphical model:
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**Reconstruction loss** ensures that decoders reconstruct molecules and gene expressions back from the latent codes produced by the encoders. We also use a cross-reconstruction loss, where molecular decoder *E~x~* uses shared part *s~y~* from a gene expression encoder *E~y~* for reconstruction and vice versa:
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where $l_{\text{rec}}^{\mathbf{x}}$ and $l_{\text{rec}}^{\mathbf{y}}$ are some distance measures in the molecules and gene expression space.

**Discriminator loss** is an objective that encourages distributions *p*(*s*), *p*(*z~x~*), and *p*(*z~y~*) to be independent, which means that shared and exclusive parts must learn different features. This restriction comes from a graphical model. It also encourages *p*(*s*), *p*(*z~x~*), and *p*(*z~y~*) to be standard Gaussian distributions *N*(0, *I*) to perform a sampling scheme from Equation 3. We optimized the discriminator in an adversarial manner ([@B20]) similar to SAAE:
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Note that since the target distribution for adversarial training is factorized, we expected that the trained model would learn independence of *s*, *z~x~*, and *z~y~*.

**Additional discriminator losses** We also added additional discrimination objective to explicitly encourage independence of *z~x~* from (*s~y~*, *z~y~*) and *z~y~* from (*s~x~*, *z~x~*):
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where ${z^{\prime}}_{x}$ is an exclusive latent code of *x*′, and ${z^{\prime}}_{y}$ is an exclusive latent code of *y*′. In practice, we obtain *z~x~*′ and *z~y~*′ by shuffling *z~x~* and *z~y~* in each batch.

Combining these objectives, the final optimization problem becomes a minimax problem that can be solved by alternating gradient descent with respect to encoder and decoder parameters, and gradient ascent with respect to the discriminator parameters:
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The hyperparameters λ~1~, λ~2~, and λ~3~ balance different objectives. In general, we optimize lambdas based on the performance of BiAAE on the holdout set in terms of the target metrics, such as estimated negative conditional log-likelihood. In practice, we found that optimal values of lambdas yielded the gradients of loss components on a similar scale.

Unidirectional Adversarial Autoencoder {#s3_3}
--------------------------------------

The Bidirectional AAE can generate molecules that cause given transcriptome changes and transcriptome changes caused by a given molecule. However, if we only need conditional generation of molecules *p*(*x* \| *y*), we simplify the model by removing the encoder of *s~x~*. The encoder *E~x~* returns only an exclusive part: *z~x~* = *E~x~*(*x*). For this model, we derived the objective from Equation 11 by setting *s~x~* equal to *s~y~* ([**Figure 5**](#f5){ref-type="fig"}).

![The Unidirectional Adversarial Autoencoder: a simplified version of a Bidirectional Adversarial Autoencoder for generating from ***p***(***x**\|**y***). The discriminator part ensures that the three latent code components are independent, and the object's exclusive latent code is indistinguishable from the prior distribution.](fphar-11-00269-g005){#f5}

Experimental Evaluation {#s4}
=======================

In this section, we have described the experimental setup and presented numerical results on the toy Noisy MNIST dataset and a LINCS L1000 dataset ([@B15]) of gene expression data.

Noisy MNIST {#s4_1}
-----------

We start by validating our models on the Noisy MNIST ([@B56]) dataset of image pairs (*x*, *y*), for which we know the correct features in the shared representation *s*. The image *x* is a handwritten digit randomly rotated by an angle in \[−π/4,π/4\]. The image *y* is also a randomly rotated version of another image containing the same digit as *x* but with strong additive Gaussian noise. As a result, the only common feature between *x* and *y* is the digit. Bidirectional and Unidirectional AAEs should learn to store only the information about the digit in *s*.

The train-validation-test splits contain 50,000, 10,000, and 10,000 samples respectively. We set the batch size to 128 and the learning rate to 0.0003, and we used the Adam ([@B26]) optimizer with *β*~1~ = 0.5, *β*~2~ = 0.9 for models with adversarial training and *β*~1~ = 0.99 and *β*~1~ = 0.999 for others with a single update of autoencoders per a single update of the discriminator. Encoder and decoder architectures were the same for all models, with 12-dimensional *z~x~*, *z~y~* and 4-dimensional *s*. The encoder had 2 convolutional layers with a number of channels 1 → 32 → 16 with 2D dropout rate 0.2 followed by three fully-connected layers of size 64 → 128 → 128 → 16 with batch normalization. The decoder consisted of 2 fully connected layers followed by 3 transposed convolution layers; the discriminators have two hidden layers with 1024 → 512 units. We set the weights for ℒ~rec~ to 10 and 0.1 for ℒ~shared~. Other λ were set to 1. For Unidirectional AAE, we increased weight for ℒ~info~ to 100. For baseline models we used similar architectures. Please refer to the [**Supplementary Material**](#SM1){ref-type="supplementary-material"} for additional hyperparameters.

Conditional generative model *p*(***x*** \| ***y***) should produce images with the same digit as image ***y***, which we evaluate by training a separate convolutional neural network to predict the digit from *x* and comparing the most probable digit to the actual digit of *y* known from the dataset. We also estimated a conditional mutual information *ℳℐ*(***x***,***s***~***y***~\|***y***) using a Mutual Information Neural Estimation (MINE) ([@B7]) algorithm for BiAAE, UniAAE, JMVAE, and VCCA models. For SAAE, LatentSAAE, CVAE, and VIB we estimated *ℳℐ*(***x***,***s***\|***y***) since these models do not separate embeddings into shared and exclusive parts explicitly. Models with high mutual information extract relevant information from *y*. A neural network for MINE consisted of a convolutional encoder for *x* and fully-connected encoder for *s~y~*. We then passed a concatenated embedding through a fully-connected neural network to get a final estimate of mutual information. Results in [**Table 1**](#T1){ref-type="table"} suggest that the BiAAE model extracted relevant mutual information which, besides all, contained information about the digit of *y*. In [**Figure 6**](#f6){ref-type="fig"}, we show example samples from the model.

###### 

Quantitative results for a Noisy MNIST experiment. Conditional Generation section evaluates how often the model produced a correct digit. Latent Codes section estimates the Mutual Information between *z*~*x*~ and *s* (*y* for SAAE).

  Model            Accuracy, %   MI(*x*,*s~y~*\|*y*)   MI(*x*,*s*\|*y*)
  ---------------- ------------- --------------------- ------------------
  SAAE ([@B35])    43.68         ---                   1.665
  Latent SAAE      34.76         ---                   **1.681**
  CVAE ([@B54])    0.4583        ---                   0.3074
  JMVAE ([@B55])   5.38          0.9515                ---
  VIB ([@B1])      43.6          ---                   1.121
  VCCA ([@B58])    23.35         1.239                 ---
  BiAAE (our)      **49.21**     1.432                 ---
  UniAAE (our)     47.61         **1.627**             ---

![Qualitative results on a Noisy MNIST dataset. The figure shows generated images *x* for a noisy image *y* (left column) as a condition. Generated images must have the same digit as *y*.](fphar-11-00269-g006){#f6}

Differential Gene Expression {#s4_2}
----------------------------

In this section, we have validated Bidirectional AAE on a gene expression profiles dataset with 978 genes. We use a dataset of transcriptomes from the Library of Integrated Network-based Cellular Signatures (LINCS) L1000 project ([@B15]). The database contains measurements of gene expressions before and after cells react with a molecule at a given concentration.

For each cell line, the training set contains experiments characterized by the control (ge~*b*~∈*ℝ*^978^) and perturbation-induced (ge~*a*~∈*ℝ*^978^) gene expression profiles. We represented molecular structures in the SMILES format ([@B60]; [@B59]). We augmented the dataset by randomly matching control and perturbation-induced measurements from the same plate.

We preprocessed the training dataset by removing molecules with a molecular weight less than 250 and more than 550 Da. We then removed molecules that did not contain any oxygen or nitrogen atoms or contained atoms besides C, N, S, O, F, Cl, Br, and H. Finally, we removed molecules that contained rings with more than eight atoms or tetracyclines. The resulting dataset contained 5,216 unique SMILES. Since the dataset is small, we pretrained an autoencoder on the MOSES ([@B45]) dataset and used its encoder and decoder as initial weights in all models.

For all baseline models on differential gene expressions, we used similar hyperparameters shown in [**Table 2**](#T2){ref-type="table"} (please refer to the [**Supplementary Material**](#SM1){ref-type="supplementary-material"} for the exact hyperparameters). In all experiments, we split our dataset into train, validation, and test sets, all containing different drugs. To construct a training example, we sampled a drug-dose pair, a perturbation for this drug and dose, and a control expression from the same plate as the perturbed expression.

###### 

Hyperparameters for neural networks training on gene expression data. All neural networks are fully connected, and decoders have an architecture symmetric to the encoders.

  Hyperparameter        Value
  --------------------- -------------------------------------
  Molecular Encoder     GRU; hidden size 128; 2 layers
  Expression Encoder    IN(978)→256→OUT(128)
  Difference Encoder    IN(129)→128→OUT(10 + 10)
  Discriminator         IN→1024→512→OUT(1)
  Batch Normalization   After each linear layer in encoders
  Activation Function   LeakyReLU
  Learning Rate         0.0003

We used a two-step encoder for ***y*** = (*η*, Δge) shown in [**Figure 7**](#f7){ref-type="fig"}, where Δge=ge~*a*~−ge~*b*~. We first embedded Δge with a fully-connected neural network, and then concatenated the obtained representation with a logarithm of concentration *η*. We passed the resulting vector through a final encoder. The decoder has a symmetric architecture.

![The architecture of the condition encoder for changes in the transcriptome. The input to the expression encoder is the difference between the control and perturbed expressions. We passed the dose to the last layers of the encoder.](fphar-11-00269-g007){#f7}

### Generating Molecular Structures for Gene Expression Profiles {#s4_2_1}

The proposed BiAAE model can generate molecules for given gene expression changes and vice versa. We started by experimenting with the molecular generation ([**Table 3**](#T3){ref-type="table"}). In the experiment, we reported a negative log-probability of generating the exact incubated drug *x* given the dose and gene expression change averaged over tokens *log* *p*(***x***\|Δge,*η*). We also estimated a Mutual Information *ℳℐ*(***x***,*s*~*y*~\|Δge,*η*) similar to the MNIST experiment described above. For each *η* and Δge, we generated a set of molecules *G* and estimated a fraction of valid molecules and internal diversity of *G*:
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###### 

Validation results of conditional generation *p*(*x*\|Δge,*η*).

  Model         NLL        MI(*x*,*s*~*y*~\|Δge,*η*)   MI(*x*,*s*\|Δge,*η*)   Internal Diversity   Validity
  ------------- ---------- --------------------------- ---------------------- -------------------- ----------
  SAAE          0.55       ---                         **0.11**               **0.85**             0.64
  Latent SAAE   0.55       ---                         0.00                   **0.85**             0.62
  CVAE          1.22       ---                         0.00                   0.84                 0.58
  JMVAE         1.42       0.00                        ---                    0.61                 **0.82**
  VIB           1.46       ---                         0.00                   0.17                 0.29
  VCCA          1.36       0.00                        ---                    0.53                 0.71
  BiAAE         0.77       **0.32**                    ---                    **0.85**             0.76
  UniAAE        **0.53**   0.00                        ---                    **0.85**             0.61

where *T* is a Tanimoto similarity on Morgan fingerprints. This metric shows whether a model can produce multiple candidates for a given gene expression or collapses to a single molecule.

The proposed BiAAE and UniAAE architectures show the ability to capture the dependencies in the training set and generalize to new objects from the validation set. The BiAAE model provides better mutual information while preserving valid diverse molecules.

### Comparing Generated Molecular Structures to Known Active Molecules {#s4_2_2}

In this experiment, we show that the proposed generative model (BiAAE) can produce biologically meaningful results. We used a manually curated database of bioactive molecules ChEMBL 24.1 ([@B17]) and additional profiles of gene expression knockdown from LINCS L1000 ([@B15]).

The first experiment evaluates molecular generation given a transcriptome change of a small molecule inhibitor of a specific protein. The ChEMBL dataset has experimental data on molecules that inhibit a certain human protein. We chose template molecules that are present in both LINCS molecule perturbation dataset and ChEMBL dataset. We used molecules that had inhibition concentration less than 10 *μ*M IC50 for only one protein.

The condition for molecular generation is a transcriptome change and a dose of a template molecule. Specifically, the condition is a shared part *s~y~* of the gene expression and dose embedding. The model is expected to generate molecules that are similar to known drugs. In [**Figure 8**](#f8){ref-type="fig"}, for several protein targets, we show a known inhibitor and generated molecules that could induce similar transcriptome profile changes.

![The examples of generated molecules conditioned on gene expression changes from a protein inhibitor; Real most similar inhibitors from ChEMBL are provided for comparison.](fphar-11-00269-g008){#f8}

The second experiment evaluates molecular generation given a transcriptome change of a specific gene knockdown. The LINCS dataset contains gene knockdown transcriptomes that the model was not trained on. For each gene knockdown, we found a corresponding human protein in the ChEMBL dataset. We chose template molecules that had a proven IC50 less than 10*μ*M for only one protein. The condition for molecular generation is a transcriptome change of a gene knockdown and the most common dose 10 *μ*M in LINCS. The model is expected to generate molecules that produce the same transcriptome change of gene knockdowns.

The condition is different compared to the previous experiment in a way that the gene knockdown expression profile is not induced by a small molecule but rather shows the desired behavior of the potential drug. In [**Figure 9**](#f9){ref-type="fig"}, we show generated molecules and compare them to known inhibitors of a protein corresponding to a knocked down gene. We expect these molecules to produce similar effects in gene expression to gene knockdown.

![The examples of generated molecules conditioned on gene expression changes from a gene knockdown; Real most similar inhibitors of a knocked down gene are provided for comparison.](fphar-11-00269-g009){#f9}

### Predicting Gene Expression Profiles for an Incubated Drug {#s4_2_3}

We experimented with predicting gene expression changes after drug incubation ([**Table 4**](#T4){ref-type="table"}). First, we report estimated mutual information *ℳℐ*(Δge,*η*,***s***~***x***~\|***x***) similar to the previous experiments. We also report the *R*^2^ metric, which measures the determination coefficient between the real and predicted (Δge, *η*) for a given molecule. Finally, we report a top-1 precision metric, which shows the fraction of samples for which the largest absolute change in real and predicted Δge matched.

###### 

Validation results of conditional generation ***p***(***Δge***,***η***\|***x***).

  Model         MI(Δge,*η*,*s*~*y*~\|*x*)   MI(Δge,*η*,*s*\|*x*)   Top-1 precision   *R*^2^ score
  ------------- --------------------------- ---------------------- ----------------- --------------
  SAAE          ---                         0.00                   0.58              0.26
  Latent SAAE   ---                         **0.23**               0.74              0.28
  CVAE          ---                         0.01                   0.29              **0.33**
  JMVAE         0.00                        ---                    0.0               0.03
  VIB           ---                         0.00                   ---               ---
  VCCA          0.00                        ---                    0.0               0.03
  BiAAE         0.20                        ---                    0.74              0.32
  UniAAE        **0.21**                    ---                    **0.77**          0.27

To compute *R*^2^ and top-1 precision, we only used drugs that were administered at *η* = 10 *μ*M concentration. Since we are only interested in a certain concentration, we discarded generated (Δge, *η*) tuples if *η* was far from 10 *μ*M (outside the range \[−6.5,−5.5\] in log~10~ scale). Note that VIB was not able to generate any gene expression changes near 10 *μ*M.

The experiment demonstrates that proposed UniAAE, BiAAE, and LatentSAAE models generalize well the symmetric task and show good metrics on predicting gene expression changes.

Discussion {#s5}
==========

The key advantage of the proposed model compared to the previous works is the joint adversarial learning of latent representations of paired objects. This representation improves conditional generation metrics and shows promising results in molecular generation for desired transcriptome changes.

Three discriminator neural networks ensure that the latent representations divided into shared and exclusive parts are more meaningful and useful for the conditional generation. Two additional discriminator losses help the model learn a more expressive shared part and make sure that all three parts are mutually independent.

However, adversarial training slightly complicates the training procedure for the BiAAE model. In comparison with other baseline models, the training loss contains more terms, each with a coefficient to tune. In general, we tune these coefficients using grid search, and we select the best coefficients according to the generative metrics on the validation set. In practice, we simplify the grid search and use the same coefficient for the adversarial terms *λ*~1~=*λ*~4~=*λ*~5~ since the corresponding losses have values on the same scale. We choose the search space for coefficients *λ*~2~,*λ*~3~ in a way that the second and third terms provide the gradient in the same scale as the other terms.

Another problem that arises when we use the adversarial approach is the instability of training. The instability is the consequence of the minimax nature of adversarial training ([@B20]). To overcome the instability, we use approaches described in ([@B6]), i.e., we use shallow discriminators and Adam optimizer with parameters *β*~1~=0.5,*β*~2~=0.9.

Conclusion {#s6}
==========

In this work, we proposed a Bidirectional Adversarial Autoencoder model for the generation of molecular structures for given gene expression changes. Our AAE-based architecture extracts shared information between molecule and gene expression changes and separates it from the remaining exclusive information. We showed that our model outperforms baseline conditional generative models on the Noisy MNIST dataset and the generation of molecular structures for the desired transcriptome changes.
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